Asthma is a major public health problem affecting nearly 23 million persons in the United States, including 7 million children. 1, 2 Fungi are ubiquitous in indoor and outdoor environments and have been associated with respiratory diseases, 3, 4 including childhood [5] [6] [7] [8] and adult [9] [10] [11] asthma. Despite the overwhelming and mounting evidence linking fungal exposure and asthma, the mechanistic basis for the association has often been attributed to fungal sensitization.
In addition to their ability to act as allergens, fungi can have direct immunomodulatory activities. b-Glucans account for up to 60% of the weight of the cell wall 12 and are important for recognition of fungi by the immune system. Signaling through dectin-1, the receptor for b-glucans, 13 promotes fungal immunity by inducing dendritic cells to polarize T cells toward T H 17 cells. [14] [15] [16] [17] Although asthma has long been characterized as a disease of dysregulated T H 2 immune responses to environmental allergens, accumulating evidence suggests a role for T H 17 cells, especially in patients with severe steroid-resistant asthma. 18, 19 Immunohistochemistry on bronchial biopsy specimens from asthmatic patients reveals increased IL-17A
1 cells in patients with severe asthma compared with those with mild asthma or control subjects. 20 In both adults and children, serum IL-17A levels are significantly higher in patients with severe asthmatics compared with those with mild asthma or control subjects. [21] [22] [23] Thus in addition to acting as allergens, fungi might be affecting immune responses that modify allergic asthma.
We investigated the mechanistic basis for the health effect of exposure to fungi alone and combined with allergen (house dust mite [HDM] ). We used an integrated approach combining epidemiologic and basic mechanistic studies to better understand the complex relationship between fungal exposure and asthma outcomes. 
METHODS

Study populations and variable definitions
The Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS) is an ongoing prospective birth cohort study that has been described previously. 7, [24] [25] [26] Briefly, infants who had at least 1 parent with a positive skin prick test (SPT) response to an aeroallergen and current allergy symptoms and had a gestation of 35 weeks or greater were enrolled, and a dust sample was collected from the home during the first year of life. Annually from ages 1 to 4 years and again at age 7 years, children underwent SPTs for 15 aeroallergens (meadow fescue, timothy, white oak, maple mix, American elm, red cedar, short ragweed, Alternaria species, Aspergillus fumigatus, Penicillium species mix, Cladosporium species, cat, dog, German cockroach [Blattella germanica], dust mite mix [Dermatophagoides farinae and Dermatophagoides pteronyssinus]) and 2 food allergens (milk and egg) and were assessed by a clinician for the development of allergic diseases. Fungal contamination in the homes of 288 CCAAPS children was quantified by using the Environmental Relative Moldiness Index (ERMI) metric (36 fungal species were quantified to determine the ERMI level, see Table E1 in this article's Online Repository at www.jacionline.org) developed by the US Environmental Protection Agency in conjunction with the Department of Housing and Urban Development. 27, 28 Asthma diagnosis at age 7 years was based on symptoms and spirometry in accordance with American Thoracic Society criteria. 29 Aeroallergen sensitization was defined as a positive SPT response for any of the 15 aeroallergens at 1 or more examinations between the ages of 1 and 7 years. A High ERMI value was defined as an ERMI value greater than the median (2.08). IL-17A levels were determined from serum samples, and children with levels of greater than the median (>2.48 pg/mL) were designated as having high IL-17A levels.
Children were defined as African American if either parent self-described as such. Income was dichotomized at $40,000 per year at ages 1 and 7 years. Breast-feeding was dichotomized as the child receiving no breastmilk or for less than 4 months versus for 4 or more months. Prematurity was defined as less than 37 weeks' gestation. The child was defined as having a parental history of asthma if either parent reported asthma history on enrollment. Secondhand smoke (SHS) exposure was defined as parental report of a positive response to any of the 4 questions on our published SHS screener before age 1 year. 30 Respiratory tract infection was defined as parental report of croup, whooping cough, respiratory flu, viral infection, bronchitis/bronchiolitis, pneumonia, ear infection, sinus infection, strep throat, or tonsillitis before age 1 year.
The Greater Cincinnati Pediatric Clinic Repository (GCPCR) is a clinical repository of more than 6900 participants, including more than 2500 children with asthma, which has been described previously. 31 Fungal exposure in the GCPCR was defined as parental report of the presence of fungus, mildew, or both around windows, in the bathroom, or in the basement of the child's home. Asthma was diagnosed by a physician in the Cincinnati Children's Hospital Medical Center (CCHMC) Allergy or Pulmonary Clinics or the CCHMC Emergency Department, according to diagnostic criteria outlined by the American Thoracic Society, and the Expert Panel Report 3 guidelines. 32, 33 Asthma symptom frequency was defined as the number of times per week the child experienced wheezing, shortness of breath, chest tightness and/or pain, or coughing. ) technology at Charles River Laboratories (Boston, Mass). Mice that were identified to be 99.6% C57BL/6 were used to establish a breeding colony at Charles River Laboratories to produce mice for experimental use.
Mice and fungal challenge protocol
Age-and sex-matched wild-type BALB/c and C57BL/6 mice were purchased from Harlan Laboratories (Indianapolis, Ind). The preparation of fungal spores has been described previously. 35 HDM extract was purchased from Greer Laboratories (Lenoir, NC). Curdlan was purchased from Sigma (St Louis, Mo) and linearized, as previously described. 36 Mice were lightly anesthetized with isoflurane and exposed to saline, Aspergillus versicolor spores (10 6 ), HDM (10 mg; total endotoxin, <0.3 EU), or a combination of HDM (10 mg) and A versicolor spores (10 6 ) in a volume of 50 mL administered intratracheally 3 times a week for 3 weeks and then were assessed 2 days after the last exposure, as previously described (see Fig E1, A, in this article's Online Repository at www.jacionline.org). 35 The fungal spore dose was chosen based on the concentrations of these fungi found in homes of children in the CCAAPS birth cohort. 37 For the curdlan challenge experiments, 20 mg of curdlan was used instead of spores, and animals were challenged, as described above. As indicated, 1 mg/kg dexamethasone (Sigma) was administered to the animals intraperitoneally once daily for the last 5 days of the protocol before assessment in some experiments. In the experiments with IL-17A neutralizing antibody, a rat anti-murine IL-17A antibody (200 mg, M210, Amgen) or control IgG 1 was administered to mice at the last 2 intratracheal challenges (Fig E1, A) .
Assessment of airway hyperresponsiveness, bronchoalveolar lavage fluid, lung histology, and ELISA Airway responsiveness measurement, bronchoalveolar lavage fluid (BALF) collection and analysis, HDM-specific IgE and IgG 1 measurement, and lung histology were performed, as previously described. 35, 38 For experiments with BALB/c mice, a methacholine dose range of 0 to 100 mg/mL was used. For C57BL/6 mice, the dose range was extended to 200 mg/mL because this strain is more resistant to development of airway hyperresponsiveness (AHR).
RNA isolation and real-time quantitative PCR
Total RNA was isolated from homogenized mouse lungs, as previously described. 35, 38 Real-time quantitative PCR analysis was done with LightCycler FastStart DNA master SYBR green I as a ready-to-use reaction mixture (Roche, Mannheim, Germany). cDNAs were amplified by using the following primers: 
Flow cytometry
Lung cells were isolated, as previously described, and cell viability was confirmed by means of trypan blue exclusion. 38 To assess cytokine production by T cells, approximately 500,000 lung cells were added to a 96-U-well plate in duplicate before being stimulated with phorbol 12-myristate 13-acetate (50 ng/mL, Sigma) and ionomycin (500 ng/mL, Sigma) and incubated at 378C for 4 hours. After the first hour, Brefeldin A (10003; eBioscience, San Diego, Calif) was added to the culture to block secretion. After ex vivo stimulation, cells from duplicate wells were pooled and transferred to a 96-V-well plate on ice, centrifuged, and resuspended in PBS containing TruStain fcX (anti-mouse CD16/32; BioLegend, San Diego, Calif). T cells were stained with anti-mouse CD4-fluorescein isothiocyanate, CD3-Alexa Fluor 700, gd T-cell receptor-phycoerythrin/Cy7 and CD44-Pacific Blue (BioLegend). Cells were labeled with the LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Invitrogen by Life Technologies, Carlsbad, Calif). Intracellular staining for IL-13-phycoerythrin, IL-17A-Alexa Fluor 647, and IFN-g-PerCP5.5 was conducted according to the manufacturer's instructions (eBioscience). Acquisition was done on a FACSCanto III (Becton Dickinson, Mountain View, Calif) and analyzed with FlowJo software (Tree Star, Ashland, Ore).
Statistical analysis
For human data, statistical analyses were performed in SAS software (SAS Institute, Cary, NC). x 2 Tests were used to evaluate differences in the proportion of children with asthma at age 7 years between the groups with high/low ERMI values and positive/negative SPT responses (CCAAPS), to assess the proportion of children with high ERMI values and asthma with the various covariates (CCAAPS), to assess the proportion of children with high IL-17A levels between the groups with high and low ERMI values (CCAAPS), and to assess the proportion of children with fungal exposure history among the severe and mild asthma subgroups (GCPCR). For the murine studies, statistical analyses were performed with Prism software (GraphPad Software, La Jolla, Calif). Statistical significance was assessed by using 1-way ANOVA, followed by a Bonferroni posttest on the relevant groups, except when described otherwise in the figure legend. For all analyses, a P value of less than .05 was considered significant.
Study approval
This study was approved by the Institutional Review Board Committees of the CCHMC and the University of Cincinnati. All mice were housed in a specific pathogen-free environment in the animal facility at CCHMC. All procedures were performed in accordance with the ethical guidelines in the ''Guide for the care and use of laboratory animals'' of the Institutional Animal Care and Use Committee approved by the Veterinary Services Department of the CCHMC.
RESULTS
Exposure to fungal species is associated with increased asthma prevalence in CCAAPS children independent of fungal sensitization Among CCAAPS children, asthma prevalence was significantly higher (34.4% vs 15.0%) in children with high levels of fungal exposure (ERMI, > _2.08) versus those with low exposure (P < .001; Fig 1, A) . To determine whether this relationship was dependent on sensitization, we stratified by aeroallergen sensitization. The effect of fungal exposure on asthma prevalence remained among the group with positive SPT responses (P <.001) but was not significant in the group with negative SPT responses (Fig 1, B) . Thus both fungal exposure and allergen sensitization were required to increase asthma prevalence, suggesting that fungus might have a contribution independent of its role as an allergen. To determine whether fungal sensitization was required for the observed effect, we examined children with high ERMI values who had positive SPT responses to at least 1 aeroallergen but were not sensitized to fungus. Exposure to high levels of fungus was associated with increased asthma prevalence at age 7 years, even in the absence of fungal sensitization from ages 1 to 7 years (P 5 .003; Fig 1,  C) . Thus fungal sensitization was not required for the effect of fungal exposure on asthma prevalence. Fungal exposure is associated with increased asthma prevalence at age 7 years among CCAAPS children. A, Prevalence of asthma at age 7 years in ERMI-high versus ERMI-low exposed children (P < .001). B, Data in Fig 1, A, stratified by SPT response positivity to 1 or more environmental allergens any time during ages 1 to 7 years (P < .001). C, Data in Fig 1, B, excluding children with fungus sensitivity (P 5 .003). **P < .01 and ***P < .001. ns, Not significant.
We next evaluated the effects of other factors (sex, race, income, breast-feeding, prematurity, parental asthma, SHS exposure, and respiratory tract infection) on both fungal exposure and asthma. Children with high ERMI values were less likely to be male (P 5 .04) and have had a respiratory tract infection before age 1 year (P 5 .03). They were more likely to be African American (P 5 .03) and have a family income of less than $40,000 per year at age 7 years (P 5 .03) than children with low ERMI values (Table I) . Asthma was significantly associated with African American race (P 5 .03), income at ages 1 and 7 years (P 5 .01 and P < .001, respectively), breast-feeding (P 5 .02), parental history of asthma (P 5 .01), SHS exposure (P < .01), having a positive SPT response to an aeroallergen at between 1 and 7 years of age (P 5.03), and having a respiratory tract infection before age 1 year (P < .001, Table I ).
We next adjusted for these covariates in a multivariate logistic model of asthma, as assessed at age 7 years. Because race and income are highly correlated and income at age 7 years was associated with both asthma and ERMI values, we included only income at age 7 years in the model as an adjustment for Bar 5 50 mm. D, BALF cell differential counts. Eos, Eosinophils; Lymph, lymphocytes; Macro, macrophages; Neutro, neutrophils. E, IL-17A expression in lung tissue was assessed by using quantitative PCR and ELISA. F, IL-4 and IL-13 mRNA levels in lung tissue were assessed by using quantitative PCR. *P < .05, **P < .01, and ***P < .001, 2-way ANOVA for AHR. ns, Not significant. Data are from 3 separate experiments (n 5 6 for control and A versicolor treatment groups, n 5 7 for HDM and H1A treatment groups) and presented as means 6 SEMs. Asp, A versicolor; H1A, HDM plus A versicolor; SAL, saline.
socioeconomic status. Even after adjustment, high ERMI values were significantly and independently predictive of asthma at age 7 years (odds ratio [OR], 3.54; 95% CI, 1.85-6.81; P < .001; Table II ).
Because we previously observed an effect of high ERMI values only in children with positive SPT responses, we ran the same model, restricting to those children with positive aeroallergen responses at any time between ages 1 and 7 years. Among those with positive SPT responses, having a high ERMI value was associated with almost 4.5 times higher risk of asthma than having a low ERMI value (OR, 4.38; 95% CI, 2.08-9.22; P < .001; Table II ). We also restricted the model further to include only those with positive aeroallergen SPT responses but who were never sensitized to fungi and observed similar results (OR, 7.36; 95% CI, 2.13-25.43; P < .01; Table II) .
Collectively, these data indicate that exposure to fungus has an effect on asthma independent of the ability of fungus to act as an allergen. Furthermore, the combination of exposure to fungus plus sensitization to an environmental allergen in childhood is independently associated with increased likelihood of asthma development.
Coexposure to HDM and A versicolor synergistically induces more severe asthma characterized by increased AHR and airway inflammation To explore the immunologic basis for our epidemiologic findings, we used an experimental asthma model of coexposure to A versicolor, a fungal species commonly found in the homes of CCAAPS children, 27 and HDM as outlined in Fig E1, A. A significant increase in AHR (at a methacholine dose of 100 mg/mL, 1.65-fold vs HDM and 2.26-fold vs A versicolor) and BALF (3.06-fold vs HDM and 2.42-fold vs A versicolor) inflammation was observed when BALB/c mice were coexposed to both A versicolor and HDM compared with exposure to either alone (Fig 2, A and B) . Similarly, lung tissue from coexposed mice showed increased inflammation compared with that in mice exposed to either HDM or A versicolor alone (Fig 2, C) . Although exposure to A versicolor alone did not significantly affect total IgE or IgG 1 levels, coexposure to both HDM and A versicolor significantly increased total IgE and IgG 1 levels (data not shown) and HDM-specific IgE and IgG 1 levels compared with exposure to HDM alone (16.5-fold increase for HDM-specific IgE and 5.5-fold increase for HDM-specific IgG 1 ; see Fig E1, B) . Thus fungal exposure exacerbated HDM sensitization.
Exposure to A versicolor induces T H 17 responses and further exacerbates HDM-induced T H 2 responses
We next characterized the nature of the immune responses triggered after exposure to HDM and A versicolor alone and in combination. Exposure to A versicolor induced neutrophilic inflammation in the BALF, whereas eosinophils predominated after HDM exposure (Fig 2, D) . In the coexposure group neutrophilic (CXCL2) and eosinophilic (IL-5 and CCL11) chemokine levels were significantly induced (see Fig E2, A and B, in this article's Online Repository at www.jacionline.org). Accordingly, coexposure to HDM and A versicolor induced a mixed inflammatory response characterized by neutrophilia and eosinophilia (see Fig E1, C) , and the magnitude of the eosinophilic response was increased 2.54-fold compared with that after HDM exposure alone (Fig 2, D) . Next, we assessed the expression of T H 1, T H 2, and T H 17 cytokines in the lungs after exposure to A versicolor and HDM. Exposure to A versicolor induced a strong T H 17 response, including IL-17A, IL-17F, and IL-22, whereas HDM exposure did not induce an IL-17A response (Fig 2, E , and see Fig E2, C) . Expression of IL-6 and IL-23 was also strongly induced by A versicolor but not HDM (see Fig E2, D) . Coexposure to A versicolor and HDM induced T H 17 cytokines, although the expression was not as high as for A versicolor exposure alone (Fig 2, E , and see Fig E2, C and D) . IL-4 and IL-13 levels were significantly increased after exposure to HDM or A versicolor alone. However, coexposure to HDM and A versicolor induced a significant increase in IL-4 (1.93-fold vs HDM and 2.82-fold vs A versicolor) and IL-13 (7.84-fold vs HDM and 2.06-fold vs A versicolor) levels compared with HDM or A versicolor alone Bar 5 50 mm. D, BALF cell differential counts. E and F, T H 17 and T H 2 cytokine levels in lung tissue were assessed by using either quantitative PCR (IL-17A, IL-4, and IL-13) or ELISA (IL-17A). *P < .05, **P < .01, and ***P < .001, 2-way ANOVA for AHR. Data are from 3 separate experiments (n 5 6 for control and curdlan treatment groups, n 5 9 per HDM and H1C treatment groups) and presented as means 6 SEMs. H1C, HDM plus curdlan.
J ALLERGY CLIN IMMUNOL VOLUME 139, NUMBER 1 (Fig 2, F) . Expression of IFN-g was not significantly changed after HDM exposure, A versicolor exposure, or both (see Fig E2, C) . Thus coexposure to HDM and A versicolor resulted in a mixed T H 2 and T H 17 response and an augmented T H 2 response.
Exposure to curdlan augments HDM-driven T H 2 responses and AHR characterized by mixed eosinophilic and neutrophilic inflammation
Because the effect of fungal exposure on allergic asthma prevalence in CCAAPS children was independent of fungal sensitization, we hypothesized that the effect of A versicolor exposure on asthma severity in mice was mechanistically due to the immunomodulatory properties of fungus but not fungal sensitization. To address this, we examined whether exposure to curdlan, a b-(1,3)-glucan, 39, 40 was sufficient to confer the observed effect of fungal exposure. b-Glucan is a component of the cell walls of all fungi, and we previously reported that the amount of b-glucan determines the effect of a specific fungal exposure. 41 Exposure to curdlan by itself induced neutrophilic lung inflammation (Fig 3, C and D) and CXCL1 and CXCL2 (see Fig E3, B, in this article's Online Repository at www.jacionline.org). Although exposure to curdlan alone did not induce lung eosinophils or AHR, coexposure to HDM and curdlan induced enhanced AHR (at a methacholine dose of 25 mg/mL, 1.81-fold increase compared with HDM alone), HDM sensitization (Fig 3, A- ; Fig 3, D) , and cytokines (IL-5, CCL11, CXCL1, and CXCL2; see Fig E3, A and B) compared with exposure to HDM alone. Thus b-glucan is sufficient to reconstitute the effect of exposure to A versicolor spores on asthma severity.
Curdlan induces T H 17 cytokines and further exacerbates HDM-induced T H 2 responses by signaling through dectin-1
Exposure to curdlan alone induced IL-17A and other T H 17 cytokines but no appreciable IL-4 or IL-13 mRNA expression in the lungs. In contrast, exposure to HDM induced IL-4 and IL-13 but no appreciable IL-17A or other T H 17 cytokines (Fig 3, E and F, and see Fig E3, C) . Coexposure to curdlan and HDM induced a mixed response characterized by both T H 17 and T H 2 cytokines, and the T H 2 response was significantly augmented (2.18-fold for IL-4 and 3.07-fold for IL-13 expression) compared with that seen in mice exposed to HDM alone (Fig 3, E and F , and see Fig E3, C) . Notably, the response to coexposure was characterized by IL-17A and IL-22 but not IL-17F.
Dectin-1 is the receptor for b-glucan. To determine whether the observed effect of curdlan was mediated through dectin-1, we subjected dectin-1 KO mice to the asthma model (see Fig E1, A) . HDM similarly induced increased AHR and airway inflammation in both dectin-1 KO and wild-type mice. In contrast, coexposure with curdlan resulted in further enhanced AHR and airway inflammation only in wild-type but not dectin-1 KO mice (Fig  4, A , and see Fig E5 in this article's Online Repository at www. jacionline.org). As expected, BALF neutrophil counts were dramatically decreased by 84.9% in the dectin-1 KO mice (Fig  4, A) . Thus the ability of curdlan exposure to worsen HDMinduced asthma is dependent on dectin-1.
To further validate the critical role of IL-17A, we used an IL-17A neutralizing antibody. Anti-IL-17A neutralization significantly abrogated AHR (47.3% decreased) and BALF neutrophils (64.8% decreased) in HDM plus curdlan-coexposed mice (Fig 4,  B) . Thus IL-17A directly contributes to exacerbation of allergic asthma after coexposure to curdlan.
Curdlan exposure promotes severe steroidresistant allergic asthma through activation of T H 17 responses
Severe asthma is characterized by neutrophilia, T H 17 responses, and steroid resistance. [21] [22] [23] 42 Because curdlan and HDM coexposure induced severe asthma characterized by mixed T H 2/T H 17 inflammation, we hypothesized that the ensuing asthma might be steroid resistant. Indeed, the AHR induced by HDM exposure was significantly decreased (40.21% at a methacholine dose of 25 mg/mL) after treatment with dexamethasone, whereas mice coexposed to HDM and curdlan were much more resistant to steroids, with no significant decrease in AHR (Fig 5,  A and B) . There was a significant reduction in BALF eosinophil counts after dexamethasone treatment in the HDM and Fig E1, A. **P < .01 and ****P < .0001, 2-way ANOVA for AHR (n 5 6 per group). B, Airway resistance and BALF neutrophil counts of mice treated with either IL-17A neutralizing or control IgG in HDM and curdlan-coexposed mice. **P < .01, and ***P < .001, 2-way ANOVA for AHR (n 5 8 per group). Data from 3 separate experiments are presented as means 6 SEMs. H1C, HDM plus curdlan.
coexposure groups (90.78% vs. 64.27%, respectively; Fig 5, B) , but there was significant BALF eosinophilia remaining, even after dexamethasone treatment, in the coexposed group. Mice exposed to HDM alone did not have BALF neutrophilia. Dexamethasone treatment decreased BALF neutrophil counts in the curdlanexposed group (data not shown) and in the coexposure group (39.8%), but significant neutrophils persisted even after dexamethasone treatment in coexposed mice. Thus in the coexposed group there was significant persistent BALF eosinophilia and neutrophilia, even after dexamethasone treatment. Accordingly, lung inflammation persisted in mice coexposed to HDM and curdlan compared with HDM alone after dexamethasone treatment (see Fig E6 in this article' s Online Repository at www.jacionline.org). These data collectively demonstrate that exposure to curdlan results in more severe HDM-induced allergic asthma, which is steroid resistant.
To assess the mechanistic contribution of the curdlan-induced T H 17 response to the observed steroid resistance in HDM plus curdlan-coexposed mice, we used Il17rc 2/2 mice, which are unresponsive to IL-17A and IL-17F. 43, 44 As shown in Fig 5, C, HDM and curdlan-coexposed wild-type mice were resistant to dexamethasone (3.5% response in AHR), whereas Il17rc 2/2 mice were steroid responsive, with a 58.5% response in AHR (P < .01). These data demonstrate that IL-17A/F directly contribute to steroid resistance in experimental asthma. BALF eosinophilia was essentially unchanged in the absence of Il17rc and was responsive to dexamethasone similar to that observed in wild-type mice. In contrast, BALF neutrophilia was markedly lower in Il17rc 2/2 mice (P < .05; Fig 5, C) .
Curdlan and HDM coexposure results in accumulation of IL-17A/IL-13 double-producing CD4 1 
T cells in the lungs
A recent report found that dual-positive T H 2/T H 17 cells and IL-17A are present at a higher frequency in BALF from patients with steroid-resistant asthma. 42 Furthermore, these T H 2/T H 17 cells were resistant to dexamethasone-induced cell death, and the T H 2/T H 17-predominant subgroup of patients manifested the most severe form of asthma. We hypothesized that curdlan plus HDM-coexposed mice might have higher numbers of IL-13
CD4
1 double-producing T cells in their lungs. Exposure to HDM induced accumulation of T H 2 cells in the lungs of mice as expected, whereas exposure to curdlan, but not HDM, induced T H 17 cells in the lungs (Fig 5, D 
1 double-producing effector T cells in the lungs of mice coexposed to curdlan plus HDM (7.52-fold vs HDM exposure group and 8.95-fold vs curdlan exposure group, both P < .01, as shown in Fig 5, F, and see Fig E7) . Notably, coexposure also significantly increased the number of T H 2 cells in the lungs compared with those seen in mice exposed only to HDM (Fig 5, D) .
Fungal exposure is associated with increased IL-17A serum levels and asthma severity Based on animal data, we hypothesized that children exposed to high levels of fungus would have increased IL-17A levels.
Among CCAAPS children exposed to high levels of fungus (ERMI-high group), 77% had high levels of serum IL-17A (greater than the median of 2.48 pg/mL) compared with only 38% in the ERMI-low group (P 5 .014; Fig 6, A) . We next examined asthma severity. We analyzed children with asthma in the GCPCR 31 who had available fungal exposure data (n 5 339). We predicted that asthmatic children with fungal exposure would have more severe asthma. Indeed, among asthmatic GCPCR children, more frequent symptoms (29.84% vs 17.82%, P < .05) were associated with fungal exposure (Fig 6, B) . These data support that fungal exposure promotes increased asthma symptom frequency and increased serum IL-17A levels analogous to what we observed in mice.
DISCUSSION
Our study addresses a critical question in the allergy field: Do fungi act as allergens to exert their effect on allergic inflammation? In a mouse model of asthma, our data clearly demonstrate that fungal exposure in combination with HDM allergen synergistically enhances the T H 2 response induced by HDM and that this is independent of fungal sensitization and rather depends on the immunomodulatory functions of fungal components. Curdlan was sufficient to reconstitute the effect of fungal exposure on asthma severity and steroid resistance, demonstrating that fungal sensitization is not required. Furthermore, our data indicate that exposure to intact fungal spores is not necessary to incur the negative health effect of fungal exposure on asthma, but rather exposure to fungal components (b-glucan) or fragments is sufficient. As a result, our findings are relevant to all fungi, although the magnitude of the response will differ based on b-glucan availability, as we have previously reported. 41 Our findings also demonstrate that fungal exposure promotes development of severe allergic asthma and renders it more resistant to steroids through induction of T H 17 responses. We found that the steroid resistance induced by fungal exposure is mechanistically due to fungus-dependent induction of IL-17A/F because steroid sensitivity was restored in the mice lacking IL-17RC. Furthermore, the data suggest IL-17A is most likely responsible because IL-17F was not appreciably induced by curdlan and allergen coexposure. Indeed, neutralization with anti-IL-17A largely abrogated the effect of curdlan on allergeninduced AHR and airway inflammation. Collectively, these data suggest that a subgroup of asthmatic patients with high fungal exposure and mixed T H 2/T H 17 responses might benefit from anti-IL-17A therapy alone or in combination with steroids. Although inhibition of IL-17 receptor A did not result in significant improvement among patients with moderate-tosevere asthma in a recent randomized controlled trial, 45 targeted anti-IL-17 therapy might be beneficial alone or in combination with steroids in a subset of patients with severe asthma with high fungal exposure and mixed T H 2/T H 17 responses characterized by increased serum IL-17A levels. Additional treatments that decrease IL-17A levels might improve response to steroids. In particular, vitamin D3 has been shown to inhibit IL-17A production, 46, 47 and as such, it might be beneficial in improving steroid responsiveness in fungus-exposed patients who have increased IL-17A levels. Our data provide mechanistic evidence to support the numerous epidemiologic studies that have found that mold exposure is associated with increased development and severity of childhood and adult asthma. [4] [5] [6] [7] 9, 48 Thus prevention and treatment strategies should include interventions to reduce mold exposure.
Our data suggest that the mechanistic basis for the effect of b-glucan exposure might be in part through induction of
IL-13
1 IL-17 1 effector T cells. Consistent with our mechanistic findings in mice, recent studies have implicated dual-positive T H 2/T H 17 cells in patients with steroid-resistant asthma. Irvin et al 42 analyzed the infiltrating helper T cells in BALF from asthmatic patients and assessed their response to steroid treatment in vitro. They found that dual-positive T H 2/T H 17 cells and IL-17A were present at higher frequencies in the BALF of patients with steroid-resistant asthma. These T H 2/T H 17 cells were resistant to dexamethasone-induced cell death, and the T H 2/T H 17-predominant subgroup of patients manifested the most severe form of asthma. 42 Here we found that these double-positive cells were significantly induced only in mice coexposed to HDM and curdlan. Our data provide the first mechanistic link between fungal exposure and the induction of these double-producing cells. Thus these cells might be an excellent biomarker of patients with severe steroid-resistant asthma who would benefit from additional or alternate treatment.
Most previous studies examining the relationship between fungi and asthma have not included fungal exposure assessment but rather have relied on fungal sensitization by SPTs or specific IgE measurements. 10, 11 A major advantage of our study is the use of the CCAAPS birth cohort, in which we had objective measures of fungal exposure. Because of the availability of both SPT data and objective fungal exposure measurements in CCAAPS, we were able to better tease apart the contributions of each of these on asthma outcomes. Furthermore, we integrated mouse studies with our epidemiologic findings to specifically examine the effect of fungal exposure on allergen (HDM)-induced asthma.
Although evidence supporting the association of IL-17A with asthma severity is mounting, 20, 49, 50 the factors that promote IL-17A in the context of asthma are poorly understood. In mice we observed that fungal exposure was associated with the induction of T H 17 responses and increased asthma severity. Similarly, in children fungal exposure was associated with higher levels of serum IL-17A and increased asthma symptoms. We recently demonstrated that diesel exhaust particle (DEP) exposure promotes asthma exacerbation by enhancing T H 17 responses, and anti-IL-17A abrogates the negative effects of DEPs on asthma. 38 Similarly, in children DEP exposure was associated with increased serum IL-17A levels and asthma severity. 38 In mice we found that DEP exposure results in accumulation and persistence of allergen-specific T H 2/T H 17 cells in the lungs. 51 These cells rapidly produce T H 2 and T H 17 cytokines on re-exposure to antigen. Herein we show that in mice fungal exposure also results in more severe asthma, which is resistant to steroid treatment and characterized by mixed T H 2/T H 17 responses. Similar to our previous observations with DEPs, fungal or curdlan exposure not only induced T H 17 responses but also exacerbated the T H 2 Fig  E1, A, in wild-type (Fig 5, A and B) and Il17rc 2/2 mice (Fig 5, C) , and dexamethasone (1 mg/kg) was administered intraperitoneally for the last 5 days, as indicated, before assessment of mice. Fig 5, A, Airway resistance measured in the wild-type mice (n 5 4 for control and curdlan treatment groups, n 5 6 for HDM and H1C treatment groups). Fig 5, B , Reduction of airway resistance and BALF eosinophil and neutrophil counts after dexamethasone treatment in the HDM and H1C groups in wild-type mice, respectively. response induced by HDM, resulting in a mixed phenotype that is steroid resistant. Based on our findings, we propose the 2-hit model depicted in Fig 6 . Although allergens (hit 1) play an important role in promoting asthma, there are many environmental factors, including fungi (hit 2), that can act as immunomodulators and contribute to the asthma exacerbation. These factors (including fungi, trafficrelated particulate matter, and likely viruses, such as respiratory syncytial virus and human rhinovirus, as well as other pathogen-associated molecular patterns) are important risk factors for progression to severe asthma phentoypes. When any of these factors combine with classic asthma-related T H 2 allergens, a mixed T H 2/T H 17 response can ensue. In the case of particulate matter, we have previously reported that the T H 2/T H 17 memory that ensues after coexposure to particulate matter and HDM is long-lived and increases asthma exacerbation on re-exposure. 51 Our data from CCAAPS suggest that the effects of high fungal exposure in the first year of life might similarly be long lived and persist into adolescence because the ERMI data were from the first year of life, whereas asthma outcome was from age 7 years, and the serum samples used for IL-17A measurements were from age 12 years (Fig 1) . T H 17 differentiation-related factors (IL-23, IL-6), which were induced by fungal exposure, have been reported to promote T H 2 cells to differentiate into T H 2/T H 17 double-positive cells (see Fig E2, D) .
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In conclusion, fungi have potent immunomodulatory properties (independent of fungal sensitization) and promote progression of allergic asthma to severe steroid-resistant asthma characterized by mixed T H 2/T H 17 responses. Our results provide a strong rationale for the use of alternative therapeutic strategies for these patients with difficult-to-treat asthma who account for more than 50% of asthma health care use 53 and suggest that environmental interventions to reduce mold exposure in early life might have long-term health benefits.
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Key messages
d Fungi are potent immunomodulators and have powerful effects on asthma independent of their potential to act as allergens.
d Fungal exposure promotes severe steroid-resistant asthma, and this effect can be reconstituted with b-glucan and abrogated by neutralization of IL-17A.
d In children, exposure to fungi was associated with increased prevalence and severity of asthma and increased serum IL-17A levels. 3) exposed to curdlan, HDM, or both assessed by using either ELISA (BALF, A) or quantitative PCR (lung tissue, B and C). *P < .05, **P < .01, and ***P < .001 (both H1C vs Curdlan and H1C vs HDM for CCL11), 1-way ANOVA, followed by a Bonferroni posttest. Data are presented as means 6 SEMs. H1C, HDM plus curdlan. 
